hematopoietic system
• increased in the spleen in mice treated with poly (I:C)
|
• ineffective erythropoiesis in bone marrow and spleen in mice treated with poly (I:C)
|
• 5 fold increase in splenic erythroid progenitor cells in mice treated with poly (I:C)
• 10 fold increase in primitive erythroid progenitor cells in bone marrow
• increased number of non-viable cells in both spleen and bone marrow
|
• 2 fold increase in bone marrow in mice treated with poly (I:C)
|
• decreased red blood cell number in mice treated with poly (I:C)
• 50% decrease in mature red blood cell numbers in bone marrow
|
• in mice treated with poly (I:C)
|
• in mice treated with poly (I:C)
|
• in mice treated with poly (I:C)
|
• 6 fold decrease in cell number in mice treated with poly (I:C)
• four fold decrease in B cell lineage cells in bone marrow
|
• 4 fold decrease in cell number mice treated with poly (I:C)
|
• changes in spleen architecture in mice treated with poly (I:C)
|
• in mice treated with poly (I:C)
|
immune system
• 6 fold decrease in cell number in mice treated with poly (I:C)
• four fold decrease in B cell lineage cells in bone marrow
|
• 4 fold decrease in cell number mice treated with poly (I:C)
|
• changes in spleen architecture in mice treated with poly (I:C)
|
• in mice treated with poly (I:C)
|
growth/size/body
• in mice treated with poly (I:C)
|